Prosecution Insights
Prosecution Insights
23 pending office actions • 21 art units • 23 examiners • 0 of 23 (0%) have an AI response strategy ready • 39 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 23 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 23 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (9%) |
| §103 only | 12 (52%) |
| §102 only | 2 (9%) |
| §112 only | 4 (17%) |
| No statute on record | 3 (13%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BRUTUS, JOEL F | 1 | 72.5% | +17.9% |
| OGLES, MATTHEW ERIC | 1 | 51.5% | +55.0% |
| SHOULDERS, ANNIE LEE | 1 | 72.2% | +18.9% |
| SOLOMON, JOSHUA BRENDON | 1 | 82.6% | +20.3% |
| ARMATO JR, DENNIS IGNATIUS | 1 | 56.3% | +70.0% |
| GHAND, JENNIFER LEIGH-STEWAR | 1 | 60.4% | +28.3% |
| LEWIS, PATRICK T | 1 | 74.3% | +14.5% |
| BAKSHI, PANCHAM | 1 | 77.0% | +30.1% |
| TC 3600, DOCKET | 1 | 4.2% | -1.8% |
| CHEN, VIVIAN | 1 | 57.0% | +29.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18213070 | SYSTEM TO IDENTIFY TRANSITIONS IN BRAIN STATES FROM ELECTROPHYSIOLOGICAL MARKERS IN DBS FOR DEPRESSION | TC 3600, DOCKET | 23d overdue |
| 18025750 | MULTI-MODAL SYSTEM AND METHOD FOR TRACKING RESPIRATORY HEALTH | DOWNEY, JOHN R | 13d |
| 18564391 | SYSTEMS AND METHODS OF USING NANOMEMBRANE ELECTRONICS | SOLOMON, JOSHUA BRENDON | 48d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18035484 | Composite Materials for Uses in Cardiac and Other Tissue Repair | CHEN, VIVIAN | 30d overdue |
| 18526386 | SYSTEMS AND METHODS FOR INDIVIDUALIZED TARGETING OF DEEP BRAIN STIMULATION | SHOULDERS, ANNIE LEE | 17d overdue |
| 18288503 | Handheld Auscultation Systems, Devices, and Methods | GHAND, JENNIFER LEIGH-STEWAR | 16d overdue |
| 18531138 | Systems, Devices and Methods for Noninvasively Determining Jugular Venous Pressure and/or Associated Metrics | OGLES, MATTHEW ERIC | 15d overdue |
| 18285778 | NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS | LEWIS, PATRICK T | 2d overdue |
| 18558026 | CELL POTENCY ASSAYS, PLATFORMS, AND METHODS OF USE | ARMATO JR, DENNIS IGNATIUS | 6d |
| 19037728 | SYSTEMS AND METHODS FOR MAGNETIC RESONANCE IMAGING GUIDED ROBOTICS | BRUTUS, JOEL F | 34d |
| 18564391 | SYSTEMS AND METHODS OF USING NANOMEMBRANE ELECTRONICS | SOLOMON, JOSHUA BRENDON | 48d |
| Art Unit | Apps |
|---|---|
| 3792 | 2 |
| 1629 | 2 |
| 3797 | 1 |
| 3791 | 1 |
| 3794 | 1 |
| 1651 | 1 |
| 3796 | 1 |
| 1691 | 1 |
| 1623 | 1 |
| 3685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19037728 | SYSTEMS AND METHODS FOR MAGNETIC RESONANCE IMAGING GUIDED ROBOTICS | BRUTUS, JOEL F | 3797 | — | Non-Final OA | 34d | Pending | Jan 27, 2025 |
| 18531138 | Systems, Devices and Methods for Noninvasively Determining Jugular Venous Pressure and/or Associated Metrics | OGLES, MATTHEW ERIC | 3791 | §103 | Non-Final OA | 15d overdue | Pending | Dec 06, 2023 |
| 18526386 | SYSTEMS AND METHODS FOR INDIVIDUALIZED TARGETING OF DEEP BRAIN STIMULATION | SHOULDERS, ANNIE LEE | 3794 | §103 | Non-Final OA | 17d overdue | Pending | Dec 01, 2023 |
| 18564391 | SYSTEMS AND METHODS OF USING NANOMEMBRANE ELECTRONICS | SOLOMON, JOSHUA BRENDON | 3792 | §101 | Final Rejection | 48d | Pending | Nov 27, 2023 |
| 18558026 | CELL POTENCY ASSAYS, PLATFORMS, AND METHODS OF USE | ARMATO JR, DENNIS IGNATIUS | 1651 | §112 | Non-Final OA | 6d | Pending | Oct 30, 2023 |
| 18288503 | Handheld Auscultation Systems, Devices, and Methods | GHAND, JENNIFER LEIGH-STEWAR | 3796 | §103 | Non-Final OA | 16d overdue | Pending | Oct 26, 2023 |
| 18285778 | NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS | LEWIS, PATRICK T | 1691 | §103 | Non-Final OA | 2d overdue | Pending | Oct 05, 2023 |
| 18276736 | Diruthenium Catalyst Compositions and Synthetic Processes Related Thereto | BAKSHI, PANCHAM | 1623 | §103 | Non-Final OA | 78d | Pending | Aug 10, 2023 |
| 18213070 | SYSTEM TO IDENTIFY TRANSITIONS IN BRAIN STATES FROM ELECTROPHYSIOLOGICAL MARKERS IN DBS FOR DEPRESSION | TC 3600, DOCKET | 3685 | §103 | Non-Final OA | 23d overdue | Pending | Jun 22, 2023 |
| 18035484 | Composite Materials for Uses in Cardiac and Other Tissue Repair | CHEN, VIVIAN | 1787 | §112 | Non-Final OA | 30d overdue | Pending | May 04, 2023 |
| 18030491 | Methods of Managing Side Effects of a Vasopressin Receptor Antagonist Therapy | WEDDINGTON, KEVIN E | 1629 | §102 | Non-Final OA | 79d overdue | Pending | Apr 05, 2023 |
| 18025750 | MULTI-MODAL SYSTEM AND METHOD FOR TRACKING RESPIRATORY HEALTH | DOWNEY, JOHN R | 3792 | §101 | Final Rejection | 13d | Pending | Mar 10, 2023 |
| 18041785 | 5'-SUBSTITUTED NUCLEOSIDE MONOPHOSPHATES, PRODRUGS THEREOF, AND USES RELATED THERETO | LEE, HOI YAN NMN | 1693 | Other | Non-Final OA | 8d | Pending | Feb 15, 2023 |
| 18000865 | DIRECT IN VIVO REPROGRAMMING USING TRANSCRIPTION FACTOR ETV2 GENE FOR ENDOTHELIAL CELL AND VESSEL FORMATION | KIM, TAEYOON | 1631 | §112 | Non-Final OA | 49d overdue | Pending | Dec 06, 2022 |
| 17992674 | BLOOD DNA METHYLATION BIOMARKER DIAGNOSTIC TEST FOR ANXIETY AND DEPRESSIVE DISORDERS | HORTH, LISA ANNE | 1681 | §103 | Non-Final OA | 28d | Pending | Nov 22, 2022 |
| 18045317 | Antagonism of the VIP Signaling Pathway | D' AMBROSIO, THEA | 1654 | Other | Non-Final OA | 30d overdue | Pending | Oct 10, 2022 |
| 17917315 | METHODS OF GENERATING PLURIPOTENT STEM CELL-DERIVED VASCULAR SMOOTH MUSCLE CELLS, USES, AND COMPOSITION RELATED THERETO | PRONZATI, GINA | 1633 | §103 | Non-Final OA | 21d | Pending | Oct 06, 2022 |
| 17908766 | Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof | WESTERBERG, NISSA M | 1618 | §103 | Final Rejection | 67d overdue | Pending | Sep 01, 2022 |
| 17767766 | ANTI-TN ANTIBODIES AND USES THEREOF | SANG, HONG | 1646 | §103 | Non-Final OA | 128d overdue | Pending | Apr 08, 2022 |
| 17573730 | ANTI-CD40 ANTIBODIES AND USES THEREOF | YU, MISOOK | 1641 | §112 | Non-Final OA | 103d overdue | Pending | Jan 12, 2022 |
| 17613225 | ASPARAGINE ENDOPEPTIDASE (AEP) INHIBITORS, COMPOSITIONS, AND USES RELATED THERETO | DAHLIN, HEATHER RAQUEL | 1629 | §103 | Non-Final OA | 9d overdue | Pending | Nov 22, 2021 |
| 17435594 | Botanical Extracts and Compounds from Castanea Plants and Methods of Use | ISMAIL, REHANA | 1625 | §102 | Non-Final OA | 30d overdue | Pending | Sep 01, 2021 |
| 16972800 | Compositions of Transforming Growth Factor-Beta Type III Receptor and Uses for Ossification | REYNOLDS, FRED H | 1658 | §103 | Final Rejection | 51d overdue | Pending | Dec 07, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial